Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.

Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Abstract Text:

    katherine e postherKatherine E Posther,linda m mccallLinda M McCall,david h harpoleDavid H Harpole,carolyn e reedCarolyn E Reed,joe b putnamJoe B Putnam,valerie w ruschValerie W Rusch,barry a siegelBarry A Siegel,

    The American College of Surgeons Oncology Group recently completed a trial evaluating the role of PET with 18F-FDG in patients with documented or suspected non-small cell lung cancer. Subjects underwent standard imaging to exclude metastatic disease before PET. Here, we report the yield of brain PET in evaluating, for potential intracranial metastases, patients who have undergone previous brain CT or MRI with negative findings. METHODS: A total of 287 evaluable patients who had been registered from 22 institutions underwent whole-body 18F-FDG PET, including dedicated PET of the brain, after routine staging procedures had found no suggestion of metastatic disease. Patients were followed postoperatively for disease-free and overall survival, with a minimum follow-up of 6 mo. Patients with specific brain abnormalities identified by PET were further examined, and the findings were evaluated along with the results of CT and MRI, clinical management, and follow-up. RESULTS: In 4 patients, PET found focal 18F-FDG uptake in the brain suggestive of metastatic disease; however, metastatic disease was excluded clinically in all 4 by negative findings on further brain imaging. All 4 patients remained alive at follow-up (mean duration, 10.5 mo; range, 6-16 mo). CONCLUSION: In patients with suspected or proven non-small cell lung cancer considered resectable by standard imaging, including routine preoperative contrast-enhanced CT or MRI of the brain, PET of the brain provides no additional information regarding metastatic disease.

    Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Publishing Authors By Initials

    ke postherKE Posther,lm mccallLM McCall,dh harpoleDH Harpole,ce reedCE Reed,jb putnamJB Putnam,vw ruschVW Rusch,ba siegelBA Siegel,

    For similar diagnosis: diagnostic techniques and procedures: diagnostic imaging: whole body imaging research abstracts see: diagnosis: diagnostic techniques and procedures: diagnostic imaging: whole body imaging research

    PUBMED ID PMID:

    MEDLINE DATE:

    Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of nuclear medicine : official publication

    VOLUME: 47

    Page Numbers: 1607-11

    Journal Abbreviation: J. Nucl. Med.

    ISSN: 0161-5505

    DAY: 3

    MONTH: Oct

    YEAR: 2006

    Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 217410

    Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Keywords Mesh Terms:

    KEYWORDS: Whole Body Imaging

    MESH TERMS: diagnostic use

    Chemical & Substance for Abstract: Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. Information

    Substance Name: Fluorodeoxyglucose F18

    Registry Number: 63503-12-8

    Grant and Affiliation Information for Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.

    AFFILIATION: Department of Surgery, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: U10 CA76001-09

    ACRONYM: CA

    MEDLINETA: J Nucl Med

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News